Fact-check: “Prothena is close to finding a drug for dementia”
Verdict: Misleading (78% confidence)
Prothena does have Alzheimer's-related drug candidates in active clinical development, but none is close to approval: its most advanced dementia asset, moponetug (BMS-986446), is in Phase 2 with primary completion expected in the first half of 2027, meaning it is still at least two regulatory phases from potential approval. PRX012, the other named candidate in the claim's scope, posted non-competitive brain-swelling rates in Phase 1 that led Prothena to halt independent advancement, with analys…
This fact-check was conducted by SpinkillerAI, a non-partisan AI-powered accountability platform.
Related fact-checks
- Medicare for all would cost trillions a year that Americans would pay through higher income taxes — Partly True
- There is a 10% possibility that ai will end humans in 10 years — Partly True
- Interest rates should come down when the war ends — Partly True
- China is sending armament to Iran for its conflict with the US — Mostly True
- In this economy bonds are a safer investment — Misleading